Blog

Brittany Parker Kerrigan: Honored to have contributed 2M to MD Anderson Cancer Center’s team in their quest for a cure for brain cancer

Photo from Brittany Parker Kerrigan/LinkedIn

Jul 22, 2024, 22:14

Brittany Parker Kerrigan: Honored to have contributed 2M to MD Anderson Cancer Center’s team in their quest for a cure for brain cancer

Brittany Parker Kerrigan, Chief Operating Officer at Lindonlight Collective, shared a post on LinkedIn:

”Very honored to have contributed 2M to MD Anderson Cancer Center‘s Michael Curran, Federica Pericle and the entire ImmunoGenesis team in their quest for a cure for brain cancer.

More on their exciting research can be found here.”

Source: Brittany Parker Kerrigan/LinkedIn

brain cancer Brittany Parker Kerrigan cancer Cancer research Federica Pericle ImmunoGenesis Lindonlight Collective MD Anderson Cancer Center Michael Curran OncoDaily Oncology

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage